The aim of the present study was to evaluate plasma levels of GDF-15 and their diagnostic validity in patients with CAD undergoing OPCAB procedure, and to assess its relations to biochemical baseline variables and clinical cardiac dysfunction. Here, GDF15 is linked to coronary artery disorder.